Scarica l'app Stockscreener
8.03
3.08%
0.24
Dopo l'orario di chiusura:
8.19
0.16
+1.99%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RLAY Giù?
Forum
Previsione
Precedente Chiudi:
$7.79
Aprire:
$8.6
Volume 24 ore:
2.84M
Relative Volume:
1.44
Capitalizzazione di mercato:
$1.39B
Reddito:
$25.55M
Utile/perdita netta:
$-341.97M
Rapporto P/E:
-2.8679
EPS:
-2.8
Flusso di cassa netto:
$-304.44M
1 W Prestazione:
+4.56%
1M Prestazione:
+30.15%
6M Prestazione:
+132.75%
1 anno Prestazione:
+67.99%
Intervallo 1D:
$7.71
$8.70
Intervallo di 1 settimana:
$7.42
$8.70
Portata 52W:
$1.775
$8.70
Relay Therapeutics Inc Stock (RLAY) Company Profile
Nome
Relay Therapeutics Inc
Settore
Industria
Telefono
617-370-8837
Indirizzo
60 HAMPSHIRE STREET, CAMBRIDGE
Confronta RLAY con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RLAY
Relay Therapeutics Inc
|
8.03 | 1.35B | 25.55M | -341.97M | -304.44M | -2.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Relay Therapeutics Inc Stock (RLAY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-04 | Ripresa | Guggenheim | Buy |
| 2025-04-17 | Iniziato | Wells Fargo | Equal Weight |
| 2024-09-10 | Ripresa | Goldman | Buy |
| 2024-09-10 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-09-10 | Downgrade | Oppenheimer | Outperform → Perform |
| 2024-05-10 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2023-04-20 | Aggiornamento | Jefferies | Underperform → Hold |
| 2023-04-19 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2023-04-13 | Iniziato | Raymond James | Outperform |
| 2023-02-03 | Iniziato | Oppenheimer | Outperform |
| 2022-09-30 | Iniziato | Barclays | Equal Weight |
| 2022-09-02 | Iniziato | Stifel | Buy |
| 2022-06-06 | Iniziato | Jefferies | Underperform |
| 2022-02-01 | Iniziato | Berenberg | Buy |
| 2021-07-21 | Iniziato | BofA Securities | Buy |
| 2020-12-15 | Reiterato | H.C. Wainwright | Buy |
| 2020-12-08 | Iniziato | JMP Securities | Mkt Outperform |
| 2020-11-05 | Iniziato | H.C. Wainwright | Buy |
| 2020-08-10 | Iniziato | Cowen | Outperform |
| 2020-08-10 | Iniziato | Goldman | Buy |
| 2020-08-10 | Iniziato | Guggenheim | Buy |
| 2020-08-10 | Iniziato | JP Morgan | Neutral |
Mostra tutto
Relay Therapeutics Inc Borsa (RLAY) Ultime notizie
Relay Therapeutics Stock Has Jumped 60% in a Year — And One Investor Just Bought Nearly 4 Million More Shares - AOL.com
Relay Therapeutics (NASDAQ:RLAY) Sets New 1-Year HighStill a Buy? - MarketBeat
Bellevue Group AG Boosts Stake in Relay Therapeutics, Inc. $RLAY - MarketBeat
Wells Fargo Upgrades Relay Therapeutics (RLAY) - Nasdaq
Why Is Relay Therapeutics Stock Gaining Friday?Relay Therapeutics (NASDAQ:RLAY) - Benzinga
RLAY Stock Receives Analyst Upgrade and Price Target Boost | RLA - GuruFocus
Relay Therapeutics stock hits 52-week high at 8.62 USD By Investing.com - Investing.com South Africa
Relay Therapeutics stock hits 52-week high at 8.62 USD - Investing.com
Relay Therapeutics Reports 'Robust Activity' in Study of Zovegalisib to Treat Breast Cancer - marketscreener.com
Relay Therapeutics (RLAY) Shares New Data from Zovegalisib Study - GuruFocus
Relay Therapeutics unveils efficacy subset analysis for zovegalisib at SABCS25 - Traders Union
Relay Therapeutics Announces Efficacy Subset Analysis of - GlobeNewswire
OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Cuts Stock Holdings in Relay Therapeutics, Inc. $RLAY - MarketBeat
149,701 Shares in Relay Therapeutics, Inc. $RLAY Acquired by HighVista Strategies LLC - MarketBeat
Here's Why Relay Therapeutics, Inc. (RLAY) is a Great Momentum Stock to Buy - MSN
Norges Bank Buys Shares of 835,874 Relay Therapeutics, Inc. $RLAY - MarketBeat
Diadema Partners LP Has $151,000 Stake in Relay Therapeutics, Inc. $RLAY - MarketBeat
Mixed Investor Sentiment Surrounds Relay Therapeutics Stock - AD HOC NEWS
Growth Value: Why Relay Therapeutics Inc stock could outperform in 20252025 Market Trends & Technical Pattern Recognition Alerts - moha.gov.vn
JPMorgan Chase & Co. Reduces Stock Holdings in Relay Therapeutics, Inc. $RLAY - MarketBeat
Relay Therapeutics (NASDAQ:RLAY) Shares Down 5%What's Next? - MarketBeat
Relay Therapeutics, Inc. $RLAY Position Lifted by Franklin Resources Inc. - MarketBeat
Is Relay Therapeutics Inc. stock gaining market shareJuly 2025 Rallies & Low Drawdown Investment Strategies - Newser
Relay Therapeutics, Inc. $RLAY Shares Bought by Geode Capital Management LLC - MarketBeat
XTX Topco Ltd Raises Stake in Relay Therapeutics, Inc. $RLAY - MarketBeat
Is Relay Therapeutics Inc. stock a buy on dipsWeekly Trade Analysis & Fast Moving Stock Trade Plans - Newser
Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
What makes Relay Therapeutics Inc. stock attractive to growth fundsMarket Performance Recap & Expert Curated Trade Ideas - moha.gov.vn
RLAY Stock Price and Chart — NASDAQ:RLAY - TradingView
Barclays Sticks to Its Buy Rating for Relay Therapeutics (RLAY) - The Globe and Mail
Relay Therapeutics stock hits 52-week high at $7.65 By Investing.com - Investing.com Nigeria
Relay Therapeutics stock hits 52-week high at $7.65 - Investing.com
Should I hold or sell Relay Therapeutics Inc. stock in 2025CEO Change & AI Based Buy and Sell Signals - newser.com
Key metrics from Relay Therapeutics Inc.’s quarterly data2025 Dividend Review & Technical Entry and Exit Alerts - newser.com
Is Relay Therapeutics Inc. stock a top momentum playJuly 2025 Drop Watch & Daily Market Momentum Tracking - newser.com
Relay Therapeutics Inc.’s volatility index tracking explainedJuly 2025 Price Swings & Capital Protection Trading Alerts - newser.com
Relay Therapeutics Inc. (RLAY) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Top 3 Biotech Stocks Capitalizing on the AI Revolution - Investing.com
Top 3 Biotech Stocks Capitalizing on the AI Revolution - Investing.com
Commit To Buy Relay Therapeutics At $5, Earn 22.4% Annualized Using Options - Nasdaq
Citizens reiterates Market Outperform rating on Relay Therapeutics stock By Investing.com - Investing.com Canada
Persistent Asset Partners Ltd Decreases Stock Position in Relay Therapeutics, Inc. $RLAY - MarketBeat
What analysts say about Relay Therapeutics Inc stockChart Pattern Recognition & Outstanding Growth Strategies - earlytimes.in
How Relay Therapeutics Inc. stock compares to growth peersTrade Performance Summary & AI Optimized Trade Strategies - newser.com
Is Relay Therapeutics Inc. stock positioned for long term growth - newser.com
Does Relay Therapeutics Inc. show high probability of reboundProduct Launch & Reliable Price Action Trade Plans - newser.com
Backtesting results for Relay Therapeutics Inc. trading strategiesShare Buyback & Growth Focused Stock Reports - newser.com
Analyzing recovery setups for Relay Therapeutics Inc. investorsEarnings Performance Report & Risk Managed Investment Entry Signals - newser.com
Relay Therapeutics Inc Azioni (RLAY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Relay Therapeutics Inc Azioni (RLAY) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Rahmer Peter | See remarks |
Oct 29 '25 |
Sale |
7.50 |
21,394 |
160,455 |
337,469 |
| Rahmer Peter | See remarks |
Oct 28 '25 |
Sale |
7.29 |
19,135 |
139,494 |
358,863 |
| Catinazzo Thomas | Chief Financial Officer |
Oct 28 '25 |
Sale |
7.29 |
21,664 |
157,931 |
313,631 |
| Bergstrom Donald A | President, R&D |
Oct 28 '25 |
Sale |
7.29 |
30,897 |
225,239 |
521,823 |
1.08%
0.91%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):